Subscribe To Our Free Newsletter |
Gland Pharma receives USFDA approval for Eribulin Mesylate Injection
Gland Pharma has received approval from the United States Food and Drug Administration (USFDA) for Eribulin Mesylate Injection, 0.5 mg/mL Single Dose Vial (Product).